Skip to content
Blerp – Lifestyle
Author:
Xeltis
Xeltis makes first commercial implant of aXess™, its vascular access device for hemodialysis
July 7, 2026
Xeltis exceeds 50% enrollment in US Pivotal trial for aXess™, its vascular access device for hemodialysis
July 2, 2026
AirJoule Technologies Announces First Quarter 2026 Results and Provides Business Update
May 15, 2026
Xeltis releases groundbreaking new 12-month EU pivotal data for aXess™ demonstrating the transformative potential in hemodialysis treatment
April 21, 2026
Xeltis receives CE mark for aXess™, its aXess hemodialysis conduit™, as it moves to commercialization
April 21, 2026